Cormack Scott Daniel 4
4 · ACHIEVE LIFE SCIENCES, INC. · Filed Sep 12, 2017
Insider Transaction Report
Form 4
Cormack Scott Daniel
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2017-09-08$3.09/sh−1,491$4,607→ 14,810 total
Holdings
- 9,685(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of restricted stock units reported by the reporting holder on August 3, 2017 in connection with the consummation of the merger on August 1, 2017 between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. and does not represent a sale by the reporting person.